Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529486588> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2529486588 endingPage "9" @default.
- W2529486588 startingPage "9" @default.
- W2529486588 abstract "Rivaroxiban is a factor Xa inhibitor and is a newer oral alternative for thromboprophylaxis after joint replacements. Its major advantage is its oral administration and hence better patient compliance. However there are some doubts about its efficacy compared to dalteparin/heparin. We have recently changed over from using dalteparin injections to rivaroxiban tablets for thromboprophylaxis after hip replacements. We assessed our results to find efficacy and specificity of its action in patients undergoing THR. 504 patients underwent hip replacement in last 2 years. 316 were treated with dalteparin injections (fragmin) for thromboprophylaxis while 189 patients were treated with oral rivaroxiban for 35 days after their hip replacement. Average haemoglobin drop at 24 hours postop was 2.79 in Rivaroxiban group compared to 3. 10 in dalteparin group. 19 patients (of 189 i.e. 10.05% ) required postop blood transfusion in rivaroxiban group as against 60 (of 315 i.e. 19.04% ) in Dalteparin group. This difference was statistically significant. Incidence of DVT was no different in either groups, but the number of patients was too small to compare this. Rivaroxiban appears to be more specific in its action and our results suggest a significant reduction in postop blood transfusion following hip replacements without any increase in rate of Deep Vein Thrombosis. We would like to present our findings and discuss role of oral thromboprophylaxis after joint replacements." @default.
- W2529486588 created "2016-10-14" @default.
- W2529486588 creator A5013802726 @default.
- W2529486588 creator A5020788747 @default.
- W2529486588 creator A5032012230 @default.
- W2529486588 creator A5044636909 @default.
- W2529486588 date "2012-03-01" @default.
- W2529486588 modified "2023-09-27" @default.
- W2529486588 title "SIGNIFICANT REDUCTION IN POSTOPERATIVE BLOOD TRANSFUSION RATE AFTER THR WITH USE OF RIVAROXIBAN FOR THROMBOPROPHYLAXIS" @default.
- W2529486588 hasPublicationYear "2012" @default.
- W2529486588 type Work @default.
- W2529486588 sameAs 2529486588 @default.
- W2529486588 citedByCount "0" @default.
- W2529486588 crossrefType "journal-article" @default.
- W2529486588 hasAuthorship W2529486588A5013802726 @default.
- W2529486588 hasAuthorship W2529486588A5020788747 @default.
- W2529486588 hasAuthorship W2529486588A5032012230 @default.
- W2529486588 hasAuthorship W2529486588A5044636909 @default.
- W2529486588 hasConcept C141071460 @default.
- W2529486588 hasConcept C2776348710 @default.
- W2529486588 hasConcept C2777417762 @default.
- W2529486588 hasConcept C2777557582 @default.
- W2529486588 hasConcept C2778336525 @default.
- W2529486588 hasConcept C2778959117 @default.
- W2529486588 hasConcept C2780014101 @default.
- W2529486588 hasConcept C2780868729 @default.
- W2529486588 hasConcept C42219234 @default.
- W2529486588 hasConcept C71924100 @default.
- W2529486588 hasConceptScore W2529486588C141071460 @default.
- W2529486588 hasConceptScore W2529486588C2776348710 @default.
- W2529486588 hasConceptScore W2529486588C2777417762 @default.
- W2529486588 hasConceptScore W2529486588C2777557582 @default.
- W2529486588 hasConceptScore W2529486588C2778336525 @default.
- W2529486588 hasConceptScore W2529486588C2778959117 @default.
- W2529486588 hasConceptScore W2529486588C2780014101 @default.
- W2529486588 hasConceptScore W2529486588C2780868729 @default.
- W2529486588 hasConceptScore W2529486588C42219234 @default.
- W2529486588 hasConceptScore W2529486588C71924100 @default.
- W2529486588 hasLocation W25294865881 @default.
- W2529486588 hasOpenAccess W2529486588 @default.
- W2529486588 hasPrimaryLocation W25294865881 @default.
- W2529486588 hasRelatedWork W155173402 @default.
- W2529486588 hasRelatedWork W188075946 @default.
- W2529486588 hasRelatedWork W2000633318 @default.
- W2529486588 hasRelatedWork W2010918512 @default.
- W2529486588 hasRelatedWork W2050905413 @default.
- W2529486588 hasRelatedWork W2349902189 @default.
- W2529486588 hasRelatedWork W2382612867 @default.
- W2529486588 hasRelatedWork W2384084488 @default.
- W2529486588 hasRelatedWork W2394508488 @default.
- W2529486588 hasRelatedWork W2497196043 @default.
- W2529486588 hasRelatedWork W2523548797 @default.
- W2529486588 hasRelatedWork W2528116970 @default.
- W2529486588 hasRelatedWork W2549234217 @default.
- W2529486588 hasRelatedWork W2562530087 @default.
- W2529486588 hasRelatedWork W2594605503 @default.
- W2529486588 hasRelatedWork W2787928254 @default.
- W2529486588 hasRelatedWork W2885346167 @default.
- W2529486588 hasRelatedWork W2987922685 @default.
- W2529486588 hasRelatedWork W3030695554 @default.
- W2529486588 hasRelatedWork W3166255384 @default.
- W2529486588 isParatext "false" @default.
- W2529486588 isRetracted "false" @default.
- W2529486588 magId "2529486588" @default.
- W2529486588 workType "article" @default.